What is the history of diabetes, when was the first National Diabetes Month, and how have diabetes statistics changed over the years?

Though Lilly has been in the spotlight for the success of its GLP-1 drugs, the pharma giant has also been investing in a ...

Nearly one-third of those patients were paying $35 or far more per month in 2019, according to the latest available data from ...

In interviews with Reuters, eight U.S. obesity specialists at universities and large health systems described a different ...

The insulin is facing supply shortages as diabetes patients increasingly turn to GLP-1 weight loss drugs such as Ozempic and ...

Eli Lilly (LLY) is reportedly preparing to launch Mounjaro in Denmark, the home country of its leading rival in the ...

First the drugs tackled diabetes. Then, with just an injection a week, they took on obesity. Now they are being found to ...

(Reuters) -Eli Lilly missed Wall Street estimates for third-quarter profit on Wednesday, hurt by higher manufacturing costs ...

Novo Nordisk and Eli Lilly are racing to increase production in a weight-loss market estimated to reach at least $100 billion ...

U.S. stock indexes gave up an early gain and ended slightly lower following a mixed set of profit reports from giants like Google’s parent company and Eli Lilly. The S&P 500 slipped 0.3% Wednesday.

Volkswagen board preparing $4.3B cost-savings plan: report. McDonald's confirms beef patties not to blame for E. coli ...

Despite supply chain issues easing, patients seeking weight-loss drugs like Wegovy and Zepbound are turning to cheaper ...